COMBINATION THERAPY COMPRISING ANTI-CCR9 ANTIBODY AND VINCRISTINE FOR CANCER

The invention provides an anti-CCR9 antibody molecule for use in a method of treatment of cancer in a mammalian subject wherein the anti-CCR9 antibody molecule is administered simultaneously, sequentially or separately with a chemotherapeutic agent selected from the group consisting of: vincristine,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	DELGADO ÁLVAREZ, Marisa, PÉREZ DÍAZ, Amparo, SIMÓN BUELA, Laureano, GARRIDO CUESTA, Pablo, SANTAMARÍA GARCÍA-MINGUILLÁN, Silvia, KREMER BARÓN, Leonor Judith, GARCÍA SANZ, José Alberto
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention provides an anti-CCR9 antibody molecule for use in a method of treatment of cancer in a mammalian subject wherein the anti-CCR9 antibody molecule is administered simultaneously, sequentially or separately with a chemotherapeutic agent selected from the group consisting of: vincristine, docetaxel, paclitaxel, nanoparticle albumin-bound paclitaxel, and vinblastine, wherein said anti-CCR9 antibody molecule and said chemotherapeutic agent are not conjugated together. Also provided are related methods of treatment.